Denosumab versus romosozumab for postmenopausal osteoporosis treatment
Abstract Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment. However, no studies have directly compared their therapeutic effects or safety in postmenopausal osteoporosis. This retrospective obser...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/1b85915e4614449ba0b1d9cc85b515ff |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|